comparemela.com

Latest Breaking News On - Pharmaceuticals - Page 1 : comparemela.com

AstraZeneca Plc Digital Transformation Strateg Report 2023: Technology Focus, Initiatives, Acquisitions, Partnership and Acquisition Network Map, ICT Budget, and Contracts

/PRNewswire/ The "AstraZeneca Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com s offering. This report.

India
Qure
Xizang
China
Dublin
Ireland
Laura-wood
Healthcare-iot-innovation-center
Acquisition-network
E-st-office-hours-call
Astrazeneca-plc
Nvidia

CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference

/PRNewswire/ The 42nd J.P. Morgan Annual Healthcare Conference（"JPMHC"）2024 is taking place on January 8-11 at San Fracisco, USA, members of Sichuan.

United-states
China
Sichuan-kelun
Biotech-biopharmaceutical-co-ltd
Kelun-group
Annual-healthcare-conference
San-fracisco
Pacific-standard-time
Kelun-biotech
Health-care-amp-hospitals
Medical-pharmaceuticals-

WBA (Walgreens Boots Alliance) Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, Partnership, Investment & Acquisition Network Map, and Other Innovation Programs

/PRNewswire/ The "WBA - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com s offering. Walgreens Boots Alliance Inc.

Dublin
Ireland
Laura-wood
Liz-earle
Walgreens
Microsoft
E-st-office-hours-call
Verizon
Walgreens-boots-alliance-inc
Alliance-healthcare
Philips
Investment-acquisition-network

Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference

/PRNewswire/ Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business.

South-korea
San-francisco
California
United-states
New-jersey
Incheon
Inch-on-gwangyoksi
Boston
Massachusetts
Prnewswire-samsung-biologics
Samsung-biologics
Samsung-biologics-america

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）

/PRNewswire/ On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor.

Canada
Taiwan
Shanghai
China
Hong-kong
Beijing
Macau
Chinese
European-union
Abbisko-therapeutics-co-ltd
European-medicines-agency

vimarsana © 2020. All Rights Reserved.